Variant report

Variant	nsv524841
Chromosome Location	chr2:177628258-177632714
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ATF2	chr2:177628630-177629258	H1-hESC	embryonic stem cell:	n/a	n/a
2	ATF2	chr2:177628674-177629170	H1-hESC	embryonic stem cell:	n/a	n/a
3	BACH1	chr2:177628663-177629142	H1-hESC	embryonic stem cell:	n/a	chr2:177628973-177628987
4	BATF	chr2:177628764-177629146	GM12878	blood:	n/a	chr2:177628977-177628987 chr2:177628972-177628983
5	BATF	chr2:177628707-177629176	GM12878	blood:	n/a	chr2:177628977-177628987 chr2:177628972-177628983
6	BCL11A	chr2:177628846-177629122	H1-hESC	embryonic stem cell:	n/a	chr2:177628975-177628984 chr2:177628976-177628985
7	CEBPB	chr2:177631132-177631350	HepG2	liver:	n/a	n/a
8	CEBPB	chr2:177628809-177629112	H1-hESC	embryonic stem cell:	n/a	n/a
9	CHD2	chr2:177628775-177629306	H1-hESC	embryonic stem cell:	n/a	n/a
10	CREB1	chr2:177628563-177629226	H1-hESC	embryonic stem cell:	n/a	n/a
11	CTBP2	chr2:177628692-177629231	H1-hESC	embryonic stem cell:	n/a	n/a
12	CTCF	chr2:177628720-177628870	GM12864	blood:	n/a	n/a
13	CUX1	chr2:177628944-177629120	GM12878	blood:	n/a	n/a
14	EBF1	chr2:177628900-177629121	GM12878	blood:	n/a	n/a
15	EBF1	chr2:177628837-177629224	GM12878	blood:	n/a	n/a
16	EP300	chr2:177628943-177629178	GM12878	blood:	n/a	chr2:177628976-177628985 chr2:177628975-177628984
17	EP300	chr2:177628862-177629140	GM12878	blood:	n/a	chr2:177628976-177628985 chr2:177628975-177628984
18	EP300	chr2:177628726-177629274	H1-hESC	embryonic stem cell:	n/a	chr2:177628976-177628985 chr2:177628975-177628984
19	FOS	chr2:177628781-177629009	MCF10A-Er-Src	breast:	n/a	chr2:177628976-177628984 chr2:177628975-177628985 chr2:177628975-177628984 chr2:177628979-177628991 chr2:177628976-177628983
20	FOS	chr2:177628695-177628956	MCF10A-Er-Src	breast:	n/a	n/a
21	GATA3	chr2:177629329-177629562	SH-SY5Y	brain:	n/a	chr2:177629341-177629350 chr2:177629338-177629354 chr2:177629332-177629349 chr2:177629343-177629350
22	GTF2F1	chr2:177628793-177629161	H1-hESC	embryonic stem cell:	n/a	n/a
23	HDAC2	chr2:177628677-177629197	H1-hESC	embryonic stem cell:	n/a	n/a
24	IRF4	chr2:177628744-177629135	GM12878	blood:	n/a	n/a
25	JUN	chr2:177628796-177629153	H1-hESC	embryonic stem cell:	n/a	chr2:177628976-177628984 chr2:177628975-177628985 chr2:177628975-177628984 chr2:177628979-177628991 chr2:177628976-177628983
26	JUND	chr2:177628538-177629399	H1-hESC	embryonic stem cell:	n/a	chr2:177628976-177628984 chr2:177628975-177628985 chr2:177628975-177628984 chr2:177628979-177628991 chr2:177628976-177628983
27	JUND	chr2:177628802-177629163	H1-hESC	embryonic stem cell:	n/a	chr2:177628976-177628984 chr2:177628975-177628985 chr2:177628975-177628984 chr2:177628979-177628991 chr2:177628976-177628983
28	JUND	chr2:177628714-177629203	H1-hESC	embryonic stem cell:	n/a	chr2:177628976-177628984 chr2:177628975-177628985 chr2:177628975-177628984 chr2:177628979-177628991 chr2:177628976-177628983
29	MAFF	chr2:177631492-177631569	HepG2	liver:	n/a	chr2:177631531-177631549
30	MAFK	chr2:177628531-177629445	H1-hESC	embryonic stem cell:	n/a	n/a
31	MAFK	chr2:177631390-177631653	HepG2	liver:	n/a	n/a
32	MAFK	chr2:177631463-177631595	HepG2	liver:	n/a	n/a
33	MAX	chr2:177628659-177629146	H1-hESC	embryonic stem cell:	n/a	chr2:177628976-177628985 chr2:177628975-177628984
34	MAX	chr2:177628698-177629221	H1-hESC	embryonic stem cell:	n/a	chr2:177628976-177628985 chr2:177628975-177628984
35	MAX	chr2:177628600-177629265	H1-hESC	embryonic stem cell:	n/a	chr2:177628976-177628985 chr2:177628975-177628984
36	MAZ	chr2:177628862-177629118	GM12878	blood:	n/a	chr2:177628976-177628985 chr2:177628975-177628984
37	MYC	chr2:177629700-177629758	H1-hESC	embryonic stem cell:	n/a	n/a
38	MYC	chr2:177628871-177628936	MCF10A-Er-Src	breast:	n/a	n/a
39	NANOG	chr2:177628815-177629139	H1-hESC	embryonic stem cell:	n/a	chr2:177629012-177629021
40	NFYB	chr2:177628454-177628859	GM12878	blood:	n/a	chr2:177628644-177628654 chr2:177628641-177628656 chr2:177628641-177628656 chr2:177628643-177628656 chr2:177628642-177628656
41	NFYB	chr2:177628454-177628783	K562	blood:	n/a	chr2:177628644-177628654 chr2:177628641-177628656 chr2:177628641-177628656 chr2:177628643-177628656 chr2:177628642-177628656
42	NRF1	chr2:177628847-177628999	GM12878	blood:	n/a	n/a
43	POLR2A	chr2:177629097-177629196	H1-hESC	embryonic stem cell:	n/a	n/a
44	POLR2A	chr2:177628702-177629055	H1-hESC	embryonic stem cell:	n/a	n/a
45	POLR2A	chr2:177632549-177632615	MCF10A-Er-Src	breast:	n/a	n/a
46	POLR2A	chr2:177628662-177629086	H1-hESC	embryonic stem cell:	n/a	n/a
47	POLR2A	chr2:177628688-177628974	H1-hESC	embryonic stem cell:	n/a	n/a
48	POU2F2	chr2:177628792-177629165	GM12878	blood:	n/a	chr2:177629012-177629020 chr2:177629011-177629020 chr2:177629010-177629020 chr2:177629009-177629021 chr2:177629007-177629025 chr2:177629011-177629022 chr2:177629009-177629023 chr2:177629010-177629020 chr2:177629006-177629027 chr2:177629012-177629019 chr2:177629008-177629023 chr2:177629011-177629021
49	POU2F2	chr2:177628693-177629196	GM12891	blood:	n/a	chr2:177629012-177629020 chr2:177629011-177629020 chr2:177629010-177629020 chr2:177629009-177629021 chr2:177629007-177629025 chr2:177629011-177629022 chr2:177629009-177629023 chr2:177629010-177629020 chr2:177629006-177629027 chr2:177629012-177629019 chr2:177629008-177629023 chr2:177629011-177629021
50	POU2F2	chr2:177628720-177629217	GM12891	blood:	n/a	chr2:177629012-177629020 chr2:177629011-177629020 chr2:177629010-177629020 chr2:177629009-177629021 chr2:177629007-177629025 chr2:177629011-177629022 chr2:177629009-177629023 chr2:177629010-177629020 chr2:177629006-177629027 chr2:177629012-177629019 chr2:177629008-177629023 chr2:177629011-177629021

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr2:177629247-177629297	SK-N-SH_RA	brain:	n/a
2	chr2:177629247-177629297	SAEC	small airway:	n/a
3	chr2:177629247-177629297	GM19239	blood:	n/a
4	chr2:177629247-177629297	LNCaP	prostate:	n/a
5	chr2:177629247-177629297	HUVEC	blood vessel:	n/a
6	chr2:177629247-177629297	ECC-1	luminal epithelium:	n/a
7	chr2:177629247-177629297	BE2_C	brain:	n/a
8	chr2:177629247-177629297	AG09319	gingival:	n/a
9	chr2:177629247-177629297	GM12878	blood:	n/a
10	chr2:177629247-177629297	HAEpiC	amniotic membrane:	n/a
11	chr2:177629247-177629297	HEEpiC	esophagus:	n/a
12	chr2:177629247-177629297	SKMC	muscle:	n/a
13	chr2:177629247-177629297	GM12892	blood:	n/a
14	chr2:177629247-177629297	NT2-D1	testis:	n/a
15	chr2:177629247-177629297	ovcar-3	ovarian:	n/a
16	chr2:177629247-177629297	MCF-7	breast:	n/a
17	chr2:177629247-177629297	SK-N-SH	brain:	n/a
18	chr2:177629247-177629297	K562	blood:	n/a
19	chr2:177629247-177629297	U87	brain:	n/a
20	chr2:177629247-177629297	HL-60	blood:	n/a
21	chr2:177629247-177629297	HPAEpiC	pulmonary alveolar:	n/a
22	chr2:177629247-177629297	CMK	blood:	n/a
23	chr2:177629247-177629297	HCT-116	colon:	n/a
24	chr2:177629247-177629297	HEK293	kidney:	embryo
25	chr2:177629247-177629297	HNPCEpiC	eye:	n/a
26	chr2:177629247-177629297	GM06990	blood:	n/a
27	chr2:177629247-177629297	AG10803	skin:	n/a
28	chr2:177629247-177629297	NB4	blood:	n/a
29	chr2:177629247-177629297	HRPEpiC	eye:	n/a
30	chr2:177629247-177629297	H1-hESC	embryonic stem cell:	embryo
31	chr2:177629247-177629297	ProgFib	skin:	n/a
32	chr2:177629247-177629297	AG04449	skin:	fetal
33	chr2:177629247-177629297	Caco-2	colon:	n/a
34	chr2:177629247-177629297	PANC-1	pancreas:	n/a
35	chr2:177629247-177629297	SK-N-MC	brain:	n/a
36	chr2:177629247-177629297	A549	lung:	n/a
37	chr2:177629247-177629297	T-47D	breast:	n/a
38	chr2:177629247-177629297	Hela-S3	cervix:	n/a
39	chr2:177629247-177629297	BJ	skin:	n/a
40	chr2:177629247-177629297	AG09309	skin:	n/a
41	chr2:177629247-177629297	PrEC	prostate:	n/a
42	chr2:177629247-177629297	NHBE	bronchial:	n/a
43	chr2:177629247-177629297	Jurkat	blood:	n/a
44	chr2:177629247-177629297	HCM	heart:	n/a
45	chr2:177629247-177629297	HIPEpiC	eye:	n/a
46	chr2:177629247-177629297	PFSK-1	brain:	n/a
47	chr2:177629247-177629297	NHDF-neo	bronchial:	n/a
48	chr2:177629247-177629297	HRE	kidney:	n/a
49	chr2:177629247-177629297	AG04450	lung:	fetal
50	chr2:177629247-177629297	HepG2	liver:	n/a

No.	Distal block	Cell Line	Cell type	Cell Stage
1	chr2:177627395..177629802-chr2:177630789..177633436,2	MCF-7	breast:
2	chr2:177632631..177635766-chr2:177643014..177646486,3	MCF-7	breast:

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-NFE2L2-5	chr2:177630795-177630839	ENSG00000230552.1

Variant related genes	Relation type
ENSG00000230552	TF binding region
ENSG00000230552	CpG island
ENSG00000230552	chromatin interactions

Extended variants
information (count: 176 )
Associated
traits (count: 47 )

Variant overlapped rSNPs/rCNVs (count:176 , 50 per page) page: 1 2 3 4

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs6706063	chr2:177628258-177628259	Enhancers Weak transcription Flanking Active TSS	Chromatin interactive region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
2	rs377276887	chr2:177628320-177628321	Enhancers Weak transcription Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
3	rs79327082	chr2:177628345-177628346	Enhancers Weak transcription Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
4	rs534420876	chr2:177628377-177628378	Enhancers Weak transcription Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
5	rs559214636	chr2:177628378-177628379	Enhancers Weak transcription Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
6	rs573928301	chr2:177628410-177628411	Flanking Active TSS Enhancers Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
7	rs10179698	chr2:177628457-177628458	Flanking Active TSS Enhancers Weak transcription	TF binding region Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
8	rs35465954	chr2:177628507-177628508	Flanking Active TSS Enhancers Weak transcription	TF binding region Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
9	rs34834633	chr2:177628522-177628523	Flanking Active TSS Enhancers Weak transcription	TF binding region Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
10	rs6706426	chr2:177628528-177628529	Flanking Active TSS Enhancers Weak transcription	TF binding region Chromatin interactive region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
11	rs17612173	chr2:177628541-177628542	Flanking Active TSS Enhancers Weak transcription	TF binding region Chromatin interactive region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
12	rs6750532	chr2:177628580-177628581	Flanking Active TSS Enhancers Weak transcription	TF binding region Chromatin interactive region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
13	rs542099028	chr2:177628598-177628599	Flanking Active TSS Enhancers Weak transcription	TF binding region Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
14	rs564846080	chr2:177628675-177628676	Flanking Active TSS Enhancers Weak transcription	TF binding region Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
15	rs181946588	chr2:177628676-177628677	Flanking Active TSS Enhancers Weak transcription	TF binding region Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
16	rs138966157	chr2:177628677-177628678	Flanking Active TSS Enhancers Weak transcription	TF binding region Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
17	rs148998172	chr2:177628678-177628679	Flanking Active TSS Enhancers Weak transcription	TF binding region Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
18	rs376483001	chr2:177628679-177628680	Flanking Active TSS Enhancers Weak transcription	TF binding region Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
19	rs112121729	chr2:177628681-177628682	Flanking Active TSS Enhancers Weak transcription	TF binding region Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
20	rs540749880	chr2:177628705-177628706	Flanking Active TSS Enhancers Weak transcription	TF binding region Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
21	rs369606199	chr2:177628732-177628733	Flanking Active TSS Enhancers Weak transcription	TF binding region Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
22	rs185670750	chr2:177628763-177628764	Flanking Active TSS Enhancers Weak transcription	TF binding region Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
23	rs533856591	chr2:177628769-177628770	Flanking Active TSS Enhancers Weak transcription	TF binding region Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
24	rs72931455	chr2:177628785-177628786	Flanking Active TSS Enhancers Weak transcription	TF binding region Chromatin interactive region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
25	rs529629070	chr2:177628786-177628787	Flanking Active TSS Enhancers Weak transcription	TF binding region Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
26	rs546192697	chr2:177628813-177628814	Enhancers Flanking Active TSS Bivalent Enhancer Weak transcription	TF binding region Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
27	rs148127151	chr2:177628866-177628867	Enhancers Flanking Active TSS Bivalent Enhancer Weak transcription	TF binding region Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
28	rs575427713	chr2:177628898-177628899	Enhancers Flanking Active TSS Bivalent Enhancer Weak transcription	TF binding region Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
29	rs4894197	chr2:177628917-177628918	Enhancers Flanking Active TSS Bivalent Enhancer Weak transcription	TF binding region Chromatin interactive region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
30	rs528007408	chr2:177628922-177628923	Enhancers Flanking Active TSS Bivalent Enhancer Weak transcription	TF binding region Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
31	rs552762578	chr2:177628939-177628940	Enhancers Flanking Active TSS Bivalent Enhancer Weak transcription	TF binding region Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
32	rs200307616	chr2:177629078-177629079	Enhancers Flanking Active TSS Weak transcription Bivalent Enhancer	TF binding region Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
33	rs74514061	chr2:177629085-177629086	Enhancers Flanking Active TSS Weak transcription Bivalent Enhancer	TF binding region Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
34	rs112986338	chr2:177629114-177629115	Enhancers Flanking Active TSS Weak transcription Bivalent Enhancer	TF binding region Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
35	rs556423895	chr2:177629126-177629127	Enhancers Flanking Active TSS Weak transcription Bivalent Enhancer	TF binding region Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
36	rs190547463	chr2:177629132-177629133	Enhancers Flanking Active TSS Weak transcription Bivalent Enhancer	TF binding region Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
37	rs568427316	chr2:177629173-177629174	Enhancers Flanking Active TSS Weak transcription Bivalent Enhancer	TF binding region Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
38	rs555429068	chr2:177629188-177629189	Enhancers Flanking Active TSS Weak transcription Bivalent Enhancer	TF binding region Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
39	rs183829436	chr2:177629194-177629195	Enhancers Flanking Active TSS Weak transcription Bivalent Enhancer	TF binding region Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
40	rs552315960	chr2:177629209-177629210	Enhancers Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
41	rs554159816	chr2:177629230-177629231	Enhancers Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
42	rs571978076	chr2:177629245-177629246	Enhancers Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
43	rs370195000	chr2:177629345-177629346	Enhancers Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
44	rs545704834	chr2:177629370-177629371	Enhancers Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
45	rs557486002	chr2:177629371-177629372	Enhancers Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
46	rs575881196	chr2:177629378-177629379	Enhancers Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
47	rs4894198	chr2:177629404-177629405	Enhancers Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
48	rs186344343	chr2:177629406-177629407	Enhancers Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
49	rs143032586	chr2:177629439-177629440	Enhancers Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
50	rs191542278	chr2:177629447-177629448	Enhancers Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:47)

Disease	PMID	Source
Breast cancer	17603634	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Medulloblastoma	21979893	CNVD
Ependymoma	16718352	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Intellectual disability	22102821	CNVD
Autism	18522746	CNVD
Neurodevelopmental disorder	22521361	CNVD
Melanoma	18172304	CNVD
Cancer	16751803	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Acute lymphoblastic leukemia	21980252	CNVD
Seminomas	18059402	CNVD
Testicular germ cell tumor	18059402	CNVD
Breast cancer	16272173	CNVD
Ewing''s sarcoma	17952124	CNVD
Cancer	21637783	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Liposarcoma	21253554	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Embryonal rhabdomyosarcoma	16790082	CNVD
Autism	16446308	CNVD
Autism	19401682	CNVD
Colorectal cancer	16272173	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Lung cancer	18438408	CNVD
Glioblastoma	21080181	CNVD
Invasive pancreatic ductal carcinoma	16982739	CNVD
Prostate cancer	16573809	CNVD
High-grade prostatic intraepithelial neoplasia	16573809	CNVD
Prostate cancer	18632612	CNVD
Myelofibrosis	22110671	CNVD
Hirschsprung''s Disease	21712996	CNVD
Donnai-Barrow syndrome	21085971	CNVD
Breast cancer	21045282	CNVD
Limb abnormalities	22140379	CNVD
Sudden cardiac death	19188705	CNVD
Non-syndromic sensorineural hearing loss	18496225	CNVD
Acute myeloid leukemia	20729466	CNVD
Breast cancer	21364760	CNVD
Ovarian cancer	21720365	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD
small cell lung cancer	20016488	CNVD

Chromatin state (count:70 , 50 per page) page: 1 2

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr2:177622600-177628600	Weak transcription	iPS DF 6.9 Cell Line	embryonic stem cell
2	chr2:177622800-177628600	Weak transcription	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
3	chr2:177623000-177628400	Weak transcription	Skeletal Muscle Female	skeletal muscle
4	chr2:177623400-177634400	Weak transcription	Right Atrium	heart
5	chr2:177626800-177628600	Enhancers	iPS-15b Cell Line	embryonic stem cell
6	chr2:177626800-177628800	Enhancers	Fetal Heart	heart
7	chr2:177627000-177628400	Enhancers	HUES64 Cell Line	embryonic stem cell
8	chr2:177627000-177628600	Enhancers	H1 Cell Line	embryonic stem cell
9	chr2:177627000-177628600	Enhancers	HUES6 Cell Line	embryonic stem cell
10	chr2:177627000-177629000	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
11	chr2:177627000-177629200	Enhancers	iPS-18 Cell Line	embryonic stem cell
12	chr2:177627200-177628400	Enhancers	ES-I3 Cell Line	embryonic stem cell
13	chr2:177627400-177628800	Enhancers	NHDF-Ad	bronchial
14	chr2:177627800-177628800	Flanking Active TSS	iPS-20b Cell Line	embryonic stem cell
15	chr2:177627800-177629600	Enhancers	Brain Germinal Matrix	brain
16	chr2:177628000-177630600	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
17	chr2:177628200-177629200	Enhancers	Ganglion Eminence derived primary cultured neurospheres	brain
18	chr2:177628200-177629400	Enhancers	Fetal Brain Female	brain
19	chr2:177628200-177629600	Flanking Active TSS	HUES48 Cell Line	embryonic stem cell
20	chr2:177628200-177629800	Enhancers	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
21	chr2:177628400-177628600	Enhancers	GM12878-XiMat	blood
22	chr2:177628400-177628800	Flanking Active TSS	ES-I3 Cell Line	embryonic stem cell
23	chr2:177628400-177628800	Flanking Active TSS	HUES64 Cell Line	embryonic stem cell
24	chr2:177628400-177628800	Enhancers	Ovary	ovary
25	chr2:177628400-177629000	Enhancers	Skeletal Muscle Female	skeletal muscle
26	chr2:177628400-177631000	Enhancers	H9 Cell Line	embryonic stem cell
27	chr2:177628600-177628800	Flanking Active TSS	H1 Cell Line	embryonic stem cell
28	chr2:177628600-177629000	Flanking Active TSS	iPS-15b Cell Line	embryonic stem cell
29	chr2:177628600-177629000	Flanking Active TSS	GM12878-XiMat	blood
30	chr2:177628600-177629200	Enhancers	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
31	chr2:177628600-177629200	Enhancers	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
32	chr2:177628600-177629400	Flanking Active TSS	HUES6 Cell Line	embryonic stem cell
33	chr2:177628600-177631200	Enhancers	iPS DF 6.9 Cell Line	embryonic stem cell
34	chr2:177628800-177629000	Enhancers	H1 Cell Line	embryonic stem cell
35	chr2:177628800-177629000	Enhancers	Left Ventricle	heart
36	chr2:177628800-177629200	Enhancers	iPS-20b Cell Line	embryonic stem cell
37	chr2:177628800-177629200	Bivalent Enhancer	Fetal Brain Male	brain
38	chr2:177628800-177630400	Enhancers	Primary B cells from peripheral blood	blood
39	chr2:177628800-177630800	Enhancers	HUES64 Cell Line	embryonic stem cell
40	chr2:177628800-177631400	Enhancers	ES-I3 Cell Line	embryonic stem cell
41	chr2:177628800-177655400	Weak transcription	Ovary	ovary
42	chr2:177629000-177629200	Flanking Active TSS	H1 Cell Line	embryonic stem cell
43	chr2:177629000-177629200	Enhancers	iPS-15b Cell Line	embryonic stem cell
44	chr2:177629000-177629200	Enhancers	GM12878-XiMat	blood
45	chr2:177629000-177629400	Weak transcription	ES-UCSF4 Cell Line	embryonic stem cell
46	chr2:177629000-177630800	Weak transcription	Skeletal Muscle Female	skeletal muscle
47	chr2:177629200-177629400	Flanking Active TSS	iPS-15b Cell Line	embryonic stem cell
48	chr2:177629200-177629600	Flanking Active TSS	iPS-18 Cell Line	embryonic stem cell
49	chr2:177629200-177629600	Flanking Active TSS	iPS-20b Cell Line	embryonic stem cell
50	chr2:177629200-177630800	Enhancers	ES-WA7 Cell Line	embryonic stem cell

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links